Effect of Immunosuppressive or Immunomodulatory Agents on Severe COVID-19 Outcomes: A Population-Based Cohort Study.

Shelby Marozoff, Jeremiah Tan,Na Lu, Ayesha Kirmani,Jonathan M Loree,Hui Xie,Diane Lacaille,Jacek A Kopec,John M Esdaile, Bonnie Corradetti,Peter Malone,Cheryl L Koehn, Philippa Mennell, Alison M Hoens,J Antonio Aviña-Zubieta

ACR open rheumatology（2023）

引用 0|浏览0

暂无评分

摘要

Current use of MMF and glucocorticoids were associated with an increased risk of severe COVID-19 outcomes compared with nonuse. These results emphasize the variety of circumstances of patients taking IIAs.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要